comparemela.com

Latest Breaking News On - Jonathan eckard - Page 1 : comparemela.com

Tyme Technologies : Annual Report (Form 10-K)

tyme-10k 20220331.htm Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 . | May 25, 2022

New yorkUnited statesUnited kingdomSanta monicaNew jerseyMonte carloGeorgetown universityDistrict of columbiaJanm van tornoutBarbarac galainiJames biehlJonathan eckardTimothyc tysonJan van tornoutFrank mongielloSant chawla

TYME Technologies, Inc to Present at H C Wainwright Bioconnect Virtual Conference

BEDMINSTER, N.J. (BUSINESS WIRE) TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that Richie Cunningham, Chief Executive Officer, and Jonathan Eckard, Chief Business Officer, will present at the H.

Lisam wilsonRichie cunninghamHc wainwright bioconnectJonathan eckardExchange commissionTechnologies incSite communicationsChief executive officerChief business officerBioconnect virtual conferencePrivate securities litigation reform act

TYME Technologies, Inc to Present at Jefferies London Healthcare Conference

TYME Technologies, Inc. (Nasdaq: TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs), today announced that Richie Cunningham, Chief Executive

Lisam wilsonRichie cunninghamJonathan eckardExchange commissionTyme technologies incSite communicationsTechnologies incChief executive officerChief business officerJefferies london healthcare conferenceMean timeEvents presentationsPrivate securities litigation reform act

vimarsana © 2020. All Rights Reserved.